Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity

ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.MethodsAll Johns Hopkins Myositis Longit...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 76; no. 4; pp. 681 - 687
Main Authors Pinal-Fernandez, Iago, Casal-Dominguez, Maria, Carrino, John A, Lahouti, Arash H, Basharat, Pari, Albayda, Jemima, Paik, Julie J, Ahlawat, Shivani, Danoff, Sonye K, Lloyd, Thomas E, Mammen, Andrew L, Christopher-Stine, Lisa
Format Journal Article
LanguageEnglish
Published United States Elsevier Limited 01.04.2017
Subjects
Online AccessGet full text
ISSN0003-4967
1468-2060
1468-2060
DOI10.1136/annrheumdis-2016-210198

Cover

Abstract ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.MethodsAll Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.ResultsThe study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.ConclusionsCompared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.
AbstractList The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.OBJECTIVESThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.All Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.METHODSAll Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.The study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.RESULTSThe study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.Compared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.CONCLUSIONSCompared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.
ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.MethodsAll Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.ResultsThe study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.ConclusionsCompared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.
Objectives The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies. Methods All Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies. Results The study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM. Conclusions Compared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.
The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies. All Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies. The study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM. Compared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.
Author Albayda, Jemima
Paik, Julie J
Ahlawat, Shivani
Danoff, Sonye K
Mammen, Andrew L
Lahouti, Arash H
Lloyd, Thomas E
Pinal-Fernandez, Iago
Christopher-Stine, Lisa
Casal-Dominguez, Maria
Carrino, John A
Basharat, Pari
AuthorAffiliation 1 National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
2 Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
AuthorAffiliation_xml – name: 2 Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– name: 1 National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Author_xml – sequence: 1
  givenname: Iago
  surname: Pinal-Fernandez
  fullname: Pinal-Fernandez, Iago
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
– sequence: 2
  givenname: Maria
  surname: Casal-Dominguez
  fullname: Casal-Dominguez, Maria
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 3
  givenname: John A
  orcidid: 0000-0003-3472-2469
  surname: Carrino
  fullname: Carrino, John A
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 4
  givenname: Arash H
  surname: Lahouti
  fullname: Lahouti, Arash H
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 5
  givenname: Pari
  surname: Basharat
  fullname: Basharat, Pari
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 6
  givenname: Jemima
  surname: Albayda
  fullname: Albayda, Jemima
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 7
  givenname: Julie J
  surname: Paik
  fullname: Paik, Julie J
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 8
  givenname: Shivani
  surname: Ahlawat
  fullname: Ahlawat, Shivani
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 9
  givenname: Sonye K
  surname: Danoff
  fullname: Danoff, Sonye K
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 10
  givenname: Thomas E
  surname: Lloyd
  fullname: Lloyd, Thomas E
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 11
  givenname: Andrew L
  surname: Mammen
  fullname: Mammen, Andrew L
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
– sequence: 12
  givenname: Lisa
  surname: Christopher-Stine
  fullname: Christopher-Stine, Lisa
  email: iagopf@yahoo.es, andrew.mammen@nih.gov
  organization: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27651398$$D View this record in MEDLINE/PubMed
BookMark eNqNkl1rFDEUhoNU7Hb1L2jAGy8czeckI1SQ4kehotR6PWRmzuxmnUnWJLO4v8U_a4ZtS-1VIZCc5HlPTk7eE3TkvAOEXlDyhlJevjXOhTVMY2djwQgtC0YJrfQjtKCi1HmrJEdoQQjhhahKdYxOYtzkkGiqn6BjpkpJeaUX6O_V2q7WeJxiOwD-enmOrcN2HCcHxQidNQk67KANPtlo3QqPe781ab1_h-FPAhftDrCHDkbzGoMJw_4mV2dGswJsXIeDz7Hv8zrZ4sfld2ym5Oeg8Z2FiE0eeDThF4QZi7CDYNP-KXrcmyHCs-t5iX5--nh19qW4-Pb5_OzDRdFIrVKhWsJM2XIhldDc6IYypqlQhknWl7TrZcVEJRvVM9EJ3TIOkgulqBISWqn4Er0_5N1OTX5zCy4FM9TbYHNN-9obW_9_4uy6XvldXeaey9zIJXp1nSD43xPEVI82tjAMxoGfYk21pkqqjD8A5ZIronmZ0Zf30I2fgsudmBOyikghWKae3y3-tuqbL86AOgD5D2MM0N8ilNSzmeo7ZqpnM9UHM2Xl6T1la5NJ1s9dsMMD9Oygb8bNgy_9B3dK5no
CODEN ARDIAO
CitedBy_id crossref_primary_10_1016_S2665_9913_23_00322_3
crossref_primary_10_2147_JIR_S270114
crossref_primary_10_1371_journal_pone_0184059
crossref_primary_10_1016_j_autrev_2018_09_008
crossref_primary_10_1016_j_jbspin_2019_01_013
crossref_primary_10_1093_rheumatology_keab900
crossref_primary_10_1093_rheumatology_keab629
crossref_primary_10_2214_AJR_20_23045
crossref_primary_10_1111_cns_14647
crossref_primary_10_1177_20584601221075796
crossref_primary_10_1186_s12891_023_06354_5
crossref_primary_10_1590_0004_282x_anp_2022_s131
crossref_primary_10_3899_jrheum_171495
crossref_primary_10_1097_WCO_0000000000000740
crossref_primary_10_1212_CON_0000000000000789
crossref_primary_10_1212_WNL_0000000000005638
crossref_primary_10_1007_s40674_023_00210_2
crossref_primary_10_3389_fneur_2023_1123380
crossref_primary_10_1093_rheumatology_keac269
crossref_primary_10_1007_s00415_024_12191_w
crossref_primary_10_1212_NXI_0000000000000523
crossref_primary_10_1007_s11926_018_0763_z
crossref_primary_10_1080_10408363_2021_2000584
crossref_primary_10_4078_jrd_2020_27_3_136
crossref_primary_10_1016_S1474_4422_18_30254_0
crossref_primary_10_2169_internalmedicine_8554_21
crossref_primary_10_1007_s00415_024_12544_5
crossref_primary_10_3389_fimmu_2024_1439807
crossref_primary_10_1007_s10067_024_07240_8
crossref_primary_10_1007_s00393_024_01523_w
crossref_primary_10_1136_annrheumdis_2018_214644
crossref_primary_10_1016_j_semarthrit_2019_04_002
crossref_primary_10_1002_mus_26660
crossref_primary_10_1007_s00415_022_11447_7
crossref_primary_10_1002_acr_23188
crossref_primary_10_1007_s11910_020_01064_0
crossref_primary_10_1002_mus_27382
crossref_primary_10_1080_20009666_2019_1571882
crossref_primary_10_1007_s11926_018_0732_6
crossref_primary_10_2301_neurosonology_37_21
crossref_primary_10_1097_BOR_0000000000000549
crossref_primary_10_1097_BOR_0000000000000547
crossref_primary_10_1002_mus_27825
crossref_primary_10_1007_s11926_019_0864_3
crossref_primary_10_1007_s13311_018_00676_2
crossref_primary_10_2169_internalmedicine_2583_23
crossref_primary_10_1212_NXI_0000000000200285
crossref_primary_10_1097_BOR_0000000000000540
crossref_primary_10_1002_mus_26731
crossref_primary_10_1016_j_nmd_2023_08_014
crossref_primary_10_3389_fimmu_2025_1455867
crossref_primary_10_1002_mus_28114
crossref_primary_10_1212_WNL_0000000000004923
crossref_primary_10_1016_j_pediatrneurol_2025_03_002
crossref_primary_10_3389_fimmu_2022_1019972
crossref_primary_10_3389_fneur_2023_1251025
crossref_primary_10_1038_s41584_020_00515_9
crossref_primary_10_3390_ijms23084301
crossref_primary_10_1007_s00296_019_04254_3
crossref_primary_10_14412_1996_7012_2019_1_95_100
crossref_primary_10_1016_j_rdc_2024_07_005
crossref_primary_10_1016_j_semarthrit_2025_152672
crossref_primary_10_1097_BOR_0000000000000832
crossref_primary_10_1111_nan_12457
crossref_primary_10_1111_ene_15174
crossref_primary_10_1080_24725625_2017_1320466
crossref_primary_10_1097_BOR_0000000000000435
crossref_primary_10_1016_j_jot_2023_07_005
crossref_primary_10_1038_nrrheum_2017_1
crossref_primary_10_1073_pnas_2217831120
crossref_primary_10_7759_cureus_10916
crossref_primary_10_1093_rheumatology_kead174
crossref_primary_10_1007_s11910_023_01250_w
crossref_primary_10_1136_annrheumdis_2018_213518
crossref_primary_10_1007_s40674_023_00201_3
crossref_primary_10_1093_omcr_omad097
crossref_primary_10_2482_haigan_61_322
crossref_primary_10_1007_s11926_020_00939_y
crossref_primary_10_1111_bpa_12954
crossref_primary_10_4103_0366_6999_222323
crossref_primary_10_1007_s00256_019_03175_3
crossref_primary_10_7759_cureus_81018
crossref_primary_10_1016_j_berh_2022_101762
crossref_primary_10_1016_j_nmd_2024_105257
crossref_primary_10_7759_cureus_40825
crossref_primary_10_1016_S1634_7072_20_43301_X
crossref_primary_10_1177_14782715241300850
crossref_primary_10_1007_s11910_024_01337_y
crossref_primary_10_1111_cen3_12831
crossref_primary_10_2214_AJR_24_31359
crossref_primary_10_1093_rheumatology_keae125
crossref_primary_10_1111_ncn3_12578
crossref_primary_10_3233_JND_221557
crossref_primary_10_1007_s10140_020_01866_2
crossref_primary_10_1016_j_nmd_2017_09_016
crossref_primary_10_3988_jcn_2024_0333
crossref_primary_10_3389_fneur_2021_670784
crossref_primary_10_1136_rmdopen_2018_000850
crossref_primary_10_1186_s13075_019_2093_6
crossref_primary_10_1038_s41584_019_0223_9
crossref_primary_10_1080_03009742_2023_2202510
crossref_primary_10_1007_s00256_021_03728_5
crossref_primary_10_1007_s40674_021_00174_1
crossref_primary_10_3390_antib13010012
crossref_primary_10_1016_j_nmd_2021_11_010
crossref_primary_10_1016_j_revmed_2020_10_379
crossref_primary_10_1038_s41598_021_89311_3
crossref_primary_10_1093_rheumatology_keaa274
crossref_primary_10_2174_1573397114666180406101850
crossref_primary_10_1093_rheumatology_kez642
crossref_primary_10_18214_jend_2022_00087
crossref_primary_10_1093_mr_roae070
crossref_primary_10_1186_s13550_017_0348_2
crossref_primary_10_1016_j_semarthrit_2020_02_009
crossref_primary_10_1016_S0001_4079_19_30341_3
crossref_primary_10_1136_practneurol_2017_001848
crossref_primary_10_17650_2222_8721_2023_13_2_72_82
crossref_primary_10_1007_s11739_019_02112_5
crossref_primary_10_1007_s11926_019_0807_z
crossref_primary_10_1002_mus_26375
crossref_primary_10_1002_eji_202250326
crossref_primary_10_1007_s11547_020_01317_5
crossref_primary_10_1016_j_nmd_2020_08_360
crossref_primary_10_1007_s40674_023_00214_y
crossref_primary_10_7759_cureus_27824
crossref_primary_10_1097_CND_0000000000000487
crossref_primary_10_1007_s40674_017_0080_0
crossref_primary_10_1016_j_nrl_2023_03_005
crossref_primary_10_1016_j_chest_2021_03_040
crossref_primary_10_46833_reumatologiasp_2017_16_4_31_38
crossref_primary_10_1007_s00256_018_3107_1
crossref_primary_10_3390_diagnostics13142316
crossref_primary_10_5692_clinicalneurol_cn_001201
crossref_primary_10_1093_rheumatology_keac286
Cites_doi 10.1093/rheumatology/ker001
10.2214/AJR.08.1764
10.1007/s002560000238
10.1056/NEJMc1506827
10.1002/mus.24661
10.1016/j.nmd.2004.02.006
10.1097/BOR.0b013e3282efdc66
10.2214/ajr.179.4.1790967
10.1002/acr.20219
10.1002/mus.24307
10.1067/mjd.2002.120621
10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
10.1093/rheumatology/kev344
10.1056/NEJM197502202920807
10.1007/s00330-015-3783-3
10.1002/ana.410380504
10.1097/RMR.0b013e31825b2c35
10.1002/art.27704
10.1002/acr.20662
10.1093/rheumatology/keu422
ContentType Journal Article
Copyright Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
Copyright_xml – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
– notice: Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88I
8AF
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9-
K9.
LK8
M0R
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
7T5
H94
5PM
DOI 10.1136/annrheumdis-2016-210198
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Consumer Health Database
Health & Medical Collection (Alumni)
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
ProQuest Central Student

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2060
EndPage 687
ExternalDocumentID PMC6019551
4321357767
27651398
10_1136_annrheumdis_2016_210198
annrheumdis
Genre Journal Article
Comparative Study
GrantInformation_xml – fundername: Intramural NIH HHS
  grantid: Z99 AR999999
GroupedDBID ---
.55
.GJ
.VT
169
23M
2WC
39C
3O-
4.4
40O
53G
5GY
5RE
5VS
6J9
7X7
7~S
88E
88I
8AF
8FE
8FH
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAXUO
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACPRK
ACQSR
ACTZY
ADBBV
ADCEG
ADFRT
ADUGQ
ADZCM
AEKJL
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
AKKEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BKNYI
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C1A
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DWQXO
E3Z
EBS
EJD
F5P
FDB
FYUFA
GNUQQ
H13
HAJ
HCIFZ
HMCUK
HYE
HZ~
IAO
IEA
IHR
INH
INR
IOF
ITC
J5H
K9-
KQ8
L7B
LK8
M0R
M1P
M2P
M7P
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
RWL
RXW
TAE
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
VVN
W2D
W8F
WH7
WOQ
X6Y
X7M
YFH
YOC
YQY
ZGI
ZXP
AAFWJ
AALRI
AAYXX
CITATION
PHGZM
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
0R~
7X8
PUEGO
7T5
H94
5PM
ID FETCH-LOGICAL-b587t-7c02a6c3457483a8b1228147a252f61df592495b7f24d48c23e534771745ec573
IEDL.DBID 7X7
ISSN 0003-4967
1468-2060
IngestDate Thu Aug 21 18:08:24 EDT 2025
Fri Sep 05 13:44:11 EDT 2025
Fri Sep 05 12:13:41 EDT 2025
Fri Jul 25 11:10:35 EDT 2025
Mon Jul 21 06:01:36 EDT 2025
Tue Jul 01 04:18:05 EDT 2025
Thu Apr 24 22:59:01 EDT 2025
Thu Apr 24 23:08:30 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Magnetic Resonance Imaging
Polymyositis
Autoantibodies
Dermatomyositis
Language English
License Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b587t-7c02a6c3457483a8b1228147a252f61df592495b7f24d48c23e534771745ec573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
IP-F and ALM are co-corresponding authors.
IP-F, MC-D, ALM and LC-S contributed equally.
ORCID 0000-0003-3472-2469
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/6019551
PMID 27651398
PQID 1882905442
PQPubID 2041045
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6019551
proquest_miscellaneous_1881757601
proquest_miscellaneous_1835370836
proquest_journals_1882905442
pubmed_primary_27651398
crossref_primary_10_1136_annrheumdis_2016_210198
crossref_citationtrail_10_1136_annrheumdis_2016_210198
bmj_primary_10_1136_annrheumdis_2016_210198
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-04-01
PublicationDateYYYYMMDD 2017-04-01
PublicationDate_xml – month: 04
  year: 2017
  text: 2017-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Kidlington
PublicationTitle Annals of the rheumatic diseases
PublicationTitleAlternate Ann Rheum Dis
PublicationYear 2017
Publisher Elsevier Limited
Publisher_xml – name: Elsevier Limited
References Hoogendijk, Amato, Lecky 2004; 14
Del Grande, Carrino, Del Grande 2011; 22
Kuo, Carrino 2007; 19
Bohan, Peter 1975; 292
Cox, Reijnierse, Van Rijswijk 2011; 50
Yao, Yip, Shrader 2016; 55
Schulze, Kotter, Ernemann 2009; 192
Griggs, Askanas, Dimauro 1995; 38
Garcia 2000; 29
O'connell, Powell, Brennan 2002; 179
Valiyil, Casciola-Rosen, Hong 2010; 62
Dalakas 2015; 373
Mammen, Pak, Williams 2012; 64
Sontheimer 2002; 46
Dion, Cherin, Payan 2002; 29
Van De Vlekkert, Maas, Hoogendijk 2015; 51
Zheng, Liu, Wang 2015; 54
Tasca, Monforte, De Fino 2015; 52
Yoshida, Kurosaka, Joh 2010; 62
Papke, Wooldridge 1996; 11
Filli, Maurer, Manoliu 2015; 25
Tasca (10.1136/annrheumdis-2016-210198_bib7) 2015; 52
Sontheimer (10.1136/annrheumdis-2016-210198_bib10) 2002; 46
Efron (10.1136/annrheumdis-2016-210198_bib16) 1993
Filli (10.1136/annrheumdis-2016-210198_bib21) 2015; 25
Del Grande (10.1136/annrheumdis-2016-210198_bib2) 2011; 22
Cox (10.1136/annrheumdis-2016-210198_bib5) 2011; 50
Yao (10.1136/annrheumdis-2016-210198_bib17) 2016; 55
Dion (10.1136/annrheumdis-2016-210198_bib6) 2002; 29
Griggs (10.1136/annrheumdis-2016-210198_bib9) 1995; 38
Garcia (10.1136/annrheumdis-2016-210198_bib3) 2000; 29
Papke (10.1136/annrheumdis-2016-210198_bib15) 1996; 11
Yoshida (10.1136/annrheumdis-2016-210198_bib4) 2010; 62
Kuo (10.1136/annrheumdis-2016-210198_bib14) 2007; 19
Hoogendijk (10.1136/annrheumdis-2016-210198_bib8) 2004; 14
Bohan (10.1136/annrheumdis-2016-210198_bib11) 1975; 292
Schulze (10.1136/annrheumdis-2016-210198_bib19) 2009; 192
Dalakas (10.1136/annrheumdis-2016-210198_bib1) 2015; 373
O'connell (10.1136/annrheumdis-2016-210198_bib18) 2002; 179
Valiyil (10.1136/annrheumdis-2016-210198_bib13) 2010; 62
Mammen (10.1136/annrheumdis-2016-210198_bib12) 2012; 64
Van De Vlekkert (10.1136/annrheumdis-2016-210198_bib20) 2015; 51
Zheng (10.1136/annrheumdis-2016-210198_bib22) 2015; 54
References_xml – volume: 50
  start-page: 1153
  year: 2011
  article-title: Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis
  publication-title: Rheumatology (Oxf)
  doi: 10.1093/rheumatology/ker001
– volume: 192
  start-page: 1708
  year: 2009
  article-title: MRI findings in inflammatory muscle diseases and their noninflammatory mimics
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.08.1764
– volume: 29
  start-page: 425
  year: 2000
  article-title: MRI in inflammatory myopathies
  publication-title: Skeletal Radiol
  doi: 10.1007/s002560000238
– volume: 29
  start-page: 1897
  year: 2002
  article-title: Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis
  publication-title: J Rheumatol
– volume: 373
  start-page: 393
  year: 2015
  article-title: Inflammatory muscle diseases
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1506827
– volume: 52
  start-page: 956
  year: 2015
  article-title: Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis
  publication-title: Muscle Nerve
  doi: 10.1002/mus.24661
– volume: 14
  start-page: 337
  year: 2004
  article-title: 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, the Netherlands
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2004.02.006
– volume: 19
  start-page: 530
  year: 2007
  article-title: Skeletal muscle imaging and inflammatory myopathies
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0b013e3282efdc66
– volume: 179
  start-page: 967
  year: 2002
  article-title: Whole-body MR imaging in the diagnosis of polymyositis
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.179.4.1790967
– volume: 62
  start-page: 1328
  year: 2010
  article-title: Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.20219
– volume: 51
  start-page: 253
  year: 2015
  article-title: Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy
  publication-title: Muscle Nerve
  doi: 10.1002/mus.24307
– volume: 46
  start-page: 626
  year: 2002
  article-title: Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?
  publication-title: J Am Acad Dermatol
  doi: 10.1067/mjd.2002.120621
– volume: 11
  start-page: 619
  year: 1996
  article-title: Econometric methods for fractional response variables With an application to 401(K) plan participation rates
  publication-title: J Appl Econ
  doi: 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
– volume: 55
  start-page: 441
  year: 2016
  article-title: Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies
  publication-title: Rheumatology (Oxf)
  doi: 10.1093/rheumatology/kev344
– volume: 292
  start-page: 403
  year: 1975
  article-title: Polymyositis and dermatomyositis (second of two parts)
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197502202920807
– volume: 25
  start-page: 3499
  year: 2015
  article-title: Whole-body MRI in adult inflammatory myopathies: do we need imaging of the trunk?
  publication-title: Eur Radiol
  doi: 10.1007/s00330-015-3783-3
– volume: 38
  start-page: 705
  year: 1995
  article-title: Inclusion body myositis and myopathies
  publication-title: Ann Neurol
  doi: 10.1002/ana.410380504
– volume: 22
  start-page: 39
  year: 2011
  article-title: Magnetic resonance imaging of inflammatory myopathies
  publication-title: Top Magn Reson Imaging
  doi: 10.1097/RMR.0b013e31825b2c35
– volume: 62
  start-page: 3751
  year: 2010
  article-title: Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27704
– volume: 64
  start-page: 269
  year: 2012
  article-title: Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.20662
– volume: 54
  start-page: 1017
  year: 2015
  article-title: Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle
  publication-title: Rheumatology (Oxf)
  doi: 10.1093/rheumatology/keu422
– volume: 373
  start-page: 393
  year: 2015
  ident: 10.1136/annrheumdis-2016-210198_bib1
  article-title: Inflammatory muscle diseases
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1506827
– volume: 46
  start-page: 626
  year: 2002
  ident: 10.1136/annrheumdis-2016-210198_bib10
  article-title: Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?
  publication-title: J Am Acad Dermatol
  doi: 10.1067/mjd.2002.120621
– volume: 54
  start-page: 1017
  year: 2015
  ident: 10.1136/annrheumdis-2016-210198_bib22
  article-title: Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle
  publication-title: Rheumatology (Oxf)
  doi: 10.1093/rheumatology/keu422
– volume: 22
  start-page: 39
  year: 2011
  ident: 10.1136/annrheumdis-2016-210198_bib2
  article-title: Magnetic resonance imaging of inflammatory myopathies
  publication-title: Top Magn Reson Imaging
  doi: 10.1097/RMR.0b013e31825b2c35
– volume: 50
  start-page: 1153
  year: 2011
  ident: 10.1136/annrheumdis-2016-210198_bib5
  article-title: Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis
  publication-title: Rheumatology (Oxf)
  doi: 10.1093/rheumatology/ker001
– volume: 14
  start-page: 337
  year: 2004
  ident: 10.1136/annrheumdis-2016-210198_bib8
  article-title: 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, the Netherlands
  publication-title: Neuromuscul Disord
  doi: 10.1016/j.nmd.2004.02.006
– volume: 292
  start-page: 403
  year: 1975
  ident: 10.1136/annrheumdis-2016-210198_bib11
  article-title: Polymyositis and dermatomyositis (second of two parts)
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197502202920807
– volume: 51
  start-page: 253
  year: 2015
  ident: 10.1136/annrheumdis-2016-210198_bib20
  article-title: Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy
  publication-title: Muscle Nerve
  doi: 10.1002/mus.24307
– volume: 62
  start-page: 3751
  year: 2010
  ident: 10.1136/annrheumdis-2016-210198_bib4
  article-title: Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27704
– volume: 52
  start-page: 956
  year: 2015
  ident: 10.1136/annrheumdis-2016-210198_bib7
  article-title: Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis
  publication-title: Muscle Nerve
  doi: 10.1002/mus.24661
– volume: 38
  start-page: 705
  year: 1995
  ident: 10.1136/annrheumdis-2016-210198_bib9
  article-title: Inclusion body myositis and myopathies
  publication-title: Ann Neurol
  doi: 10.1002/ana.410380504
– volume: 29
  start-page: 425
  year: 2000
  ident: 10.1136/annrheumdis-2016-210198_bib3
  article-title: MRI in inflammatory myopathies
  publication-title: Skeletal Radiol
  doi: 10.1007/s002560000238
– volume: 55
  start-page: 441
  year: 2016
  ident: 10.1136/annrheumdis-2016-210198_bib17
  article-title: Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies
  publication-title: Rheumatology (Oxf)
– volume: 11
  start-page: 619
  year: 1996
  ident: 10.1136/annrheumdis-2016-210198_bib15
  article-title: Econometric methods for fractional response variables With an application to 401(K) plan participation rates
  publication-title: J Appl Econ
  doi: 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
– volume: 64
  start-page: 269
  year: 2012
  ident: 10.1136/annrheumdis-2016-210198_bib12
  article-title: Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.20662
– volume: 62
  start-page: 1328
  year: 2010
  ident: 10.1136/annrheumdis-2016-210198_bib13
  article-title: Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.20219
– volume: 192
  start-page: 1708
  year: 2009
  ident: 10.1136/annrheumdis-2016-210198_bib19
  article-title: MRI findings in inflammatory muscle diseases and their noninflammatory mimics
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.08.1764
– volume: 25
  start-page: 3499
  year: 2015
  ident: 10.1136/annrheumdis-2016-210198_bib21
  article-title: Whole-body MRI in adult inflammatory myopathies: do we need imaging of the trunk?
  publication-title: Eur Radiol
  doi: 10.1007/s00330-015-3783-3
– volume: 19
  start-page: 530
  year: 2007
  ident: 10.1136/annrheumdis-2016-210198_bib14
  article-title: Skeletal muscle imaging and inflammatory myopathies
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0b013e3282efdc66
– volume: 29
  start-page: 1897
  year: 2002
  ident: 10.1136/annrheumdis-2016-210198_bib6
  article-title: Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis
  publication-title: J Rheumatol
– year: 1993
  ident: 10.1136/annrheumdis-2016-210198_bib16
– volume: 179
  start-page: 967
  year: 2002
  ident: 10.1136/annrheumdis-2016-210198_bib18
  article-title: Whole-body MR imaging in the diagnosis of polymyositis
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.179.4.1790967
SSID ssj0000818
Score 2.5679164
Snippet ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to...
The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with...
Objectives The aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to...
SourceID pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 681
SubjectTerms Adiposity
Adult
Aged
Antibodies - blood
Atrophy - diagnostic imaging
Biomarkers - blood
Dermatomyositis - diagnostic imaging
Edema
Edema - diagnostic imaging
Female
Humans
Hydroxymethylglutaryl CoA Reductases - immunology
Kinases
Magnetic Resonance Imaging
Male
Middle Aged
Muscle, Skeletal - diagnostic imaging
Muscle, Skeletal - pathology
Muscular Diseases - blood
Muscular Diseases - diagnostic imaging
Muscular Diseases - immunology
Myositis, Inclusion Body - diagnostic imaging
Necrosis - blood
Necrosis - diagnostic imaging
Necrosis - immunology
Patients
Polymyositis - diagnostic imaging
Predictive Value of Tests
Severity of Illness Index
Signal Recognition Particle - immunology
Studies
Thigh
Title Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity
URI http://ard.bmj.com/content/76/4/681.full
https://www.ncbi.nlm.nih.gov/pubmed/27651398
https://www.proquest.com/docview/1882905442
https://www.proquest.com/docview/1835370836
https://www.proquest.com/docview/1881757601
https://pubmed.ncbi.nlm.nih.gov/PMC6019551
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection (Proquest)
  customDbUrl:
  eissn: 1468-2060
  dateEnd: 20241231
  omitProxy: true
  ssIdentifier: ssj0000818
  issn: 0003-4967
  databaseCode: 7X7
  dateStart: 19390101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1468-2060
  dateEnd: 20241231
  omitProxy: true
  ssIdentifier: ssj0000818
  issn: 0003-4967
  databaseCode: BENPR
  dateStart: 19390101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZtAqWXkr63eaBCb63o6mUpvZSmJKSFDWGbwN6MLMnEobbTXfuQ39I_2xmvvekmkBZ8sJFsC2Y0-kb6ZoaQd1EFqTLwToRLxkzluWDOg9dqIgew4cAlcRg7PDlJjs_V95me9Rtui55WOdjEzlCH2uMe-Udu8chPKyU-X_1iWDUKT1f7EhoPySYHqIJabWbmxhJbboeKeWo_MT2_i8uuyMv8IrZlKBagKDxh4PqA_w0rTFZerq9Rd4Dnbf7kXwvS0RZ50iNJ-mUp-qfkQayekUeT_qz8Ofl9hqmIadkuoJlOpt9oUdECw0Ei6-JFAGvSClBj3RS4YUDL6xrrE19_ot3OOPLaaR1DLN0HGjEP8vCt4EqwQtRVgSI5kdY53DcF-zE9pa5tanzIaqQnUgcXLZECNMdusAxHrJb3gpwfHZ59PWZ9KQaWaWsaZvwYhOml0kZZ6WzGhbBcGRCmyBMeco1-nM5MLlRQ1gsZtVQGfEWlo9dGviQbVV3F14SKLMjAPdiW3Cobk_2g4tjm3keZca_diLwHEaRXy2QbaeekyC5wehBYigJLlwIbkWQQVer7rOZYXOPnv18cr17873_tDLqQ9jN9kd7o5Yi8XTXDHMWDF1fFusU-UkuDecDv62MBySFDaUReLdVrNS5hEg1IHQZg1hRv1QFzhK-3VMVFlys8wYBQzd_cP_Rt8lggXOkYSTtko5m3cRfAVpPtdTNqj2weHJ6cTv8AYWgsFA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkIAXxH86BhgJniCi_hd7SAghYGrZOqHRSX0Lju1oQUsy2lSon4XvwGfkLk06CtLgZVIfWtlJT7rz-X727-4IeRqkFzIFdMJt3I9klvHIOkCtOjAINixAEou5w6ODeHAkP07UZIP87HJhkFbZ-cTGUfvK4Rn5S2bwyk9Jyd-cfouwaxTernYtNJZmsRcW3wGyzV4P34N-n3G--2H8bhC1XQWiVBldR9r1QS4npNLSCGtSxrlhUoNcPIuZzxRCEpXqjEsvjeMiKCE1wB6pglNawHsvkctS9CXW6tcTfeb5DTNdhz65E-uWT8ZE01Rmehzmhc9nYJgsjgBqAd6HHS0tvq7viX8Fun_yNX_bAHdvkOtt5ErfLk3tJtkI5S1yZdTezd8mP8ZY-pgW8xkM09HhkOYlzTH9JERNfgrEtrSEKLWqczygoMWiwn7Ii1e0OYlHHj2tgg-FfUED1l3u3uVtAV6P2tJTJEPSKoPvdR59PvxE7byu8EdaIR2SWvjQAilHU5wG237A7nx3yNGFKOku2SyrMtwnlKdeeObAl2VGmhDveBn6JnMuiJQ5ZXvkOaggOV0W90gaUCSaRO1OYQkqLFkqrEfiTlWJa6uoYzOPk38_2F89-N__td3ZQtJ6lllytg565MlqGHwCXvTYMlRznCOU0Fh3_Lw5BiJHZET1yL2lea3k4jpWgAxAAL1meKsJWJN8faTMj5va5DEmoCq2db7oj8nVwXi0n-wPD_YekGscQ6WGDbVNNuvpPDyEQK9OHzWri5IvF72cfwE5W2RA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkCZeEP_pGGAkeIJo9b_YQ0IIMaqV0Wkam9S34NiOFrQko02F-ln4Jnw67tKkoyANXib1oZWd9KQ7n-9n_-6OkOdBeiFTQCfcxv1IZhmPrAPUqgODYMMCJLGYOzw6iPdO5MexGq-Rn10uDNIqO5_YOGpfOTwj32YGr_yUlHw7a2kRh7uDt-ffIuwghTetXTuNhYnsh_l3gG_TN8Nd0PULzgcfjt_vRW2HgShVRteRdn2Q0QmptDTCmpRxbpjUICPPYuYzhfBEpTrj0kvjuAhKSA0QSKrglBbw3mvkuhZSIJ1Mj_XFLmCY6br1yZ1Yt9wyJpoGM5PTMCt8PgUjZXEEsAuwP-xuafF1dX_8K-j9k7v522Y4uEVutlEsfbcwu9tkLZR3yMaovae_S34cYxlkWsymMExHR0OalzTHVJQQNbkqEOfSEiLWqs7xsIIW8wp7I89f0-ZUHjn1tAo-FPYVDViDuXuXtwV4QGpLT5EYSasMvtd59PnokNpZXeGPtEJqJLXwoQXSjyY4DUKAgJ367pGTK1HSfbJeVmV4SChPvfDMgV_LjDQh3vEy9E3mXBApc8r2yEtQQXK-KPSRNABJNEnbncISVFiyUFiPxJ2qEtdWVMfGHmf_frC_fPC__2urs4Wk9TLT5GJN9Miz5TD4B7z0sWWoZjhHKKGxBvllcwxEkciO6pEHC_NaysV1rAAlgAB6xfCWE7A--epImZ82dcpjTEZVbPNy0Z-SDVjIyafhwf4jcoNj1NQQo7bIej2ZhccQ89Xpk2ZxUfLlqlfzL_1QaHs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thigh+muscle+MRI+in+immune-mediated+necrotising+myopathy%3A+extensive+oedema%2C+early+muscle+damage+and+role+of+anti-SRP+autoantibodies+as+a+marker+of+severity&rft.jtitle=Annals+of+the+rheumatic+diseases&rft.au=Pinal-Fernandez%2C+Iago&rft.au=Casal-Dominguez%2C+Maria&rft.au=Carrino%2C+John+A&rft.au=Lahouti%2C+Arash+H&rft.date=2017-04-01&rft.issn=0003-4967&rft.eissn=1468-2060&rft.volume=76&rft.issue=4&rft.spage=681&rft_id=info:doi/10.1136%2Fannrheumdis-2016-210198&rft_id=info%3Apmid%2F27651398&rft.externalDBID=ard&rft.externalDocID=annrheumdis
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4967&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4967&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4967&client=summon